Prescient Therapeutics Ltd
PTX•Health Care•Biotechnology•Last updated: Dec 25
About
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company focuses on developing novel therapies for the treatment of cancer. Its main segments include targeted therapies and cell therapy enhancements. Prescient's lead programs are PTX-100 and PTX-200, which are small molecule inhibitors targeting specific cancer pathways.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- PTX
Related Shares
Investor Resources
Should you buy Prescient Therapeutics Ltd right now?
While PTX looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now